Rituximab, a chimaeric anti-CD20 monoclonal antibody, in the treatment of hairy cell leukaemia.
about
Hairy cell leukemia: current conceptsSuccessful treatment of hairy cell leukemia variant with rituximab.Treatment of hairy cell leukemia during pregnancy: are purine analogues and rituximab viable therapeutic options.Towards the pharmacotherapy of hairy cell leukaemia.My treatment approach to hairy cell leukemia.2-CdA in the treatment of hairy cell leukemia: a review of long-term follow-up.Multiply relapsing hairy cell leukemia responsive to repeated courses of rituximab: a case report.Hairy cell leukemia - immunotargets and therapiesLong-term treatment of hairy cell leukemia with interferon-α: still a viable therapeutic option.Phase II trial of recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) in patients with hairy cell leukemia.Importance of minimal residual disease in hairy cell leukemia: monoclonal antibodies as a therapeutic strategy.Approach to the patient after relapse of hairy cell leukemia.Hairy cell leukemia: short review, today's recommendations and outlook.Infectious complications in hairy cell leukemia.Hairy cell leukaemia: biological and clinical overview from immunogenetic insights.Hairy cell leukemia-new genes, new targets.Potential breakthroughs with investigational drugs for hairy cell leukemia.How I manage patients with hairy cell leukaemia.A quantitative exploration of surface antigen expression in common B-cell malignancies using flow cytometry.Long-term outcome with pentostatin treatment in hairy cell leukemia patients. A French retrospective study of 238 patients.Successful rituximab therapy for hemolytic anemia associated with relapsed splenic marginal zone lymphoma with leukemic phase.Hairy cell leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia
P2860
Q28294251-AB9A19C3-241F-4050-97D2-1AABF5C7C893Q33367714-C9BD0785-4521-4B71-8F1C-A85DE67D29D0Q33854868-41F8FAEB-7C86-432D-9876-A32ED47FA76BQ35814410-DA8DDEB4-5602-4A4F-BE51-0BD60AA6947EQ36399120-AE257080-374A-4C75-8955-C044EA0A1729Q36654614-15C767E0-5ECD-4C22-81C5-7BBDB3509A0EQ36687989-46B5C8B9-EDCB-419D-BE50-4E07C711ABA4Q37031666-FD1468B0-B491-46F0-8E43-F2FA7B09A241Q37043067-7599EC62-DD38-4674-9298-3D2E66537C55Q37242280-034C3DDF-BF38-48DB-A5C6-4CAC60030ADFQ37611077-9073C0C1-B9FB-41EC-8889-499F74D54A28Q37611080-8A1AAFBA-7C66-49B6-93FE-9A7FEA2D1DA4Q37621357-87E72CF6-E6C4-431B-A350-86CC561C715AQ37866770-2E56D556-9792-4FD9-B707-82277C58BE4CQ37889776-4FD32FA0-8F0A-43BB-BD50-979C08680008Q38124726-612B631A-BE7A-4A8F-A96D-CE901D03A056Q38578492-4C83C081-FC10-416E-A2F9-F8BBB267FB1FQ39113513-A6CAADF4-2691-4B1C-B00E-FEBC2E4D422EQ40343878-EF48386C-CD87-45B1-8469-22DA6E59F2CCQ44279389-2E6DA84B-3B57-4046-9EAB-340FCCB8C159Q51040373-C527A0C8-065B-4E91-8287-8895D4EDD6F1Q53381221-D15BD895-5400-4C4E-8467-D0BE6DE76764Q56355787-35EEC66F-01E0-4062-9D6C-609B2E02C72C
P2860
Rituximab, a chimaeric anti-CD20 monoclonal antibody, in the treatment of hairy cell leukaemia.
description
2001 nî lūn-bûn
@nan
2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Rituximab, a chimaeric anti-CD ...... tment of hairy cell leukaemia.
@ast
Rituximab, a chimaeric anti-CD ...... tment of hairy cell leukaemia.
@en
type
label
Rituximab, a chimaeric anti-CD ...... tment of hairy cell leukaemia.
@ast
Rituximab, a chimaeric anti-CD ...... tment of hairy cell leukaemia.
@en
prefLabel
Rituximab, a chimaeric anti-CD ...... tment of hairy cell leukaemia.
@ast
Rituximab, a chimaeric anti-CD ...... tment of hairy cell leukaemia.
@en
P1476
Rituximab, a chimaeric anti-CD ...... tment of hairy cell leukaemia.
@en
P2093
P2860
P304
P356
10.1046/J.1365-2141.2001.03143.X
P407
P577
2001-12-01T00:00:00Z